Detection of individualized medication of common tumor

Cancer is a common disease that is harmful to human health. Targeted therapy and chemotherapy are commonly used in cancer treatment, but the efficacy and toxicity of different patients are different. Gene mutation factor is the cause of individual difference of cancer drug reaction . According to the genotype data, rational individualized therapeutic planning is made to improve the efficacy of the drug and reduce the adverse drug reactions, thus alleviating the pain and the economic burden of  patient.

Tumor individualized medication related drugs include targeted drugs and chemotherapeutic

    Individualized targeting drugs use: detecting gene mutation information of tumor patients and selecting targeted drugs according to the results of detection 

    Individualized chemotherapy drugs use:detecting the overall genetic polymorphism information of tumor patients to evaluate the sensitivity and toxicity of chemotherapeutic drugs, and guide the selection and dosage of chemotherapeutic drugs.

Product introduction

    The product of tumor individualized medication comprehensively covers 16 kinds of targeted drugs, 3 kinds of endocrine drugs, and 18 kinds of chemotherapeutic drugs. By detecting the mutation of the patient's gene, the effect of the drugs are predicted to guide clinical medication.

Intended for

1, weak body, unable to withstand the side effects of chemotherapy

2, miss the best time, can not remove the focus through the operation 

3, first diagnosis of the patient

4.relapse or metastasis after the treatment, ineffective treatment scheme